Results 171 to 180 of about 333,009 (323)

Chinese Toxic Language Mitigation via Sentiment Polarity Consistent Rewrites [PDF]

open access: green
Xintong Wang   +5 more
openalex   +1 more source

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin   +6 more
wiley   +1 more source

Coherence in popularized medico-pharmaceutical reports: The case of EPAR summaries for the public

open access: yesRevista de Lenguas para Fines Específicos
The present article investigates a particular lay-oriented medico-pharmaceutical genre, viz. the European Public Assessment Report – summary for the public, which is a summarized version of a much longer specialized report published by the European ...
Aage Hill-Madsen
doaj  

Tunable Optical Metamaterial Enables Steganography, Rewriting, and Multilevel Information Storage. [PDF]

open access: yesNanomicro Lett
Zheng J   +9 more
europepmc   +1 more source

RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Parkinson's disease (PD) is a neurodegenerative disorder that may sometimes be caused by deleterious genetic variants. Among them, RAB39B polymorphisms are known as rare causes of early‐onset PD associated with intellectual disability (Waisman's syndrome).
Caterina Del Regno   +13 more
wiley   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy